Taroh Satoh
MD PhD
Professor
👥Biography 个人简介
Taroh Satoh at Osaka contributed to Asian gastric cancer clinical research, including participation in the REGARD and RAINBOW trials establishing ramucirumab (anti-VEGFR2) as second-line therapy in advanced gastric cancer — a significant advance in a setting with few effective options. His research on gastric cancer treatment in the Asian context where the disease is most prevalent has been important.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-03-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Taroh Satoh 的研究动态
Follow Taroh Satoh's research updates
留下邮箱，当我们发布与 Taroh Satoh（Osaka University）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment